These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 24012505

  • 1. Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders - results of an open-label, parallel group, investigator-initiated, proof-of-concept study.
    Brandt C, Schoendienst M, Trentowska M, Schrecke M, Fueratsch N, Witte-Boelt K, Pohlmann-Eden B, May TW.
    Epilepsy Behav; 2013 Nov; 29(2):298-304. PubMed ID: 24012505
    [Abstract] [Full Text] [Related]

  • 2. [Use of pregabalin and sertraline in complex treatment of patients with partial epilepsy comorbid with depressive and anxiety disorders].
    Bondarenko II, Kissin MIa.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012 Nov; 112(5):29-36. PubMed ID: 22951778
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients.
    Brandt C, May TW, Pohlmann-Eden B, Nieder E, Elsner H, Witte-Boelt K, Schuermann I, Ebner A.
    Seizure; 2009 Nov; 18(9):634-8. PubMed ID: 19674920
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey.
    Brandt C, Schoendienst M, Trentowska M, May TW, Pohlmann-Eden B, Tuschen-Caffier B, Schrecke M, Fueratsch N, Witte-Boelt K, Ebner A.
    Epilepsy Behav; 2010 Feb; 17(2):259-63. PubMed ID: 20075009
    [Abstract] [Full Text] [Related]

  • 10. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM, Almas M, Emir B, Giordano S, Leon T.
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice.
    Carreño M, Maestro I, Molins A, Donaire A, Falip M, Becerra JL, Castillo J.
    Seizure; 2007 Dec; 16(8):709-12. PubMed ID: 17604654
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sleep disturbances reported by refractory partial-onset epilepsy patients receiving polytherapy.
    Xu X, Brandenburg NA, McDermott AM, Bazil CW.
    Epilepsia; 2006 Jul; 47(7):1176-83. PubMed ID: 16886981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in seizure severity and quality of life in patients with refractory partial epilepsy.
    Sancho J, Iváñez V, Molins A, López Gómez V, Masramón X, Pérez M.
    Epilepsy Behav; 2010 Nov; 19(3):409-13. PubMed ID: 20855235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.